M42 has partnered with Toshiba Energy Systems & Solutions Corporation (Toshiba ESS) to build the Middle East’s first heavy-ion therapy facility for cancer treatment. The new facility will be ...

M42, which is backed by Mubadala Investment Company, has made a strategic investment in Juvenescence. Established in 2022, M42 is a provider of medical and healthcare services. It is based in Abu ...

M42 is investing an undisclosed amount into Juvenescence at a valuation of over $550m The announcement from M42 comes following the launch of a new well-being cluster - Health, Endurance ...